Ameriprise Financial Inc Meira G Tx Holdings PLC Transaction History

Ameriprise Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.8 - $8.98 $9,309 - $14,412	-1,605 Reduced 12.63%	11,100 $72,000
Q3 2022 Nov 14, 2022	SELL	$7.55 - $11.25 $10,570 - $15,750	-1,400 Reduced 9.93%	12,705 $107,000
Q2 2022 Aug 15, 2022	BUY	$6.8 - $14.23 $34 - $71	5 Added 0.04%	14,105 $107,000
Q1 2022 May 16, 2022	SELL	$13.42 - $23.38 $10,736 - $18,704	-800 Reduced 5.37%	14,100 $195,000
Q4 2021 Feb 14, 2022	BUY	$12.78 - $23.74 $190,422 - $353,726	14,900 New	14,900 $354,000

102

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $282M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.